In bioinformatic studies of neuroblastoma, MYCN gene amplification and the ensuing dysregulation of N-MYC function have been linked to a colder tumor phenotype (22, 23), lending further support to the notion that N-MYC activity may impair antitumor immunity. This evidence concerns the gene MYCN and neoplasm.